{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:27:29Z","timestamp":1760887649179},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.clinthera.2004.12.012","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T07:26:37Z","timestamp":1110525997000},"page":"2092-2101","source":"Crossref","is-referenced-by-count":15,"title":["Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: A randomized, open-label, two-period, comparative crossover study"],"prefix":"10.1016","volume":"26","author":[{"given":"Ji-Young","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pil-Whan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwee-Hyun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwan Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2004.12.012_bib1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults, 1999\u20132000","volume":"288","author":"Flegal","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2004.12.012_bib2","article-title":"Weight Control and Physical Activity","volume":"vol 6","author":"International Agency for Research on Cancer","year":"2002"},{"key":"10.1016\/j.clinthera.2004.12.012_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1079\/PHN19980004","article-title":"The nutrition transition and its health implications in lower-income countries","volume":"1","author":"Popkin","year":"1998","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.clinthera.2004.12.012_bib4","first-page":"1","article-title":"Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity","volume":"894","author":"World Health Organization","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.clinthera.2004.12.012_bib5","series-title":"The Asia\u2014Pacific Perspective: Redefining Obesity and Its Treatment","author":"World Health Organization","year":"2000"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2004.12.012_bib6","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0002-8223(98)00704-4","article-title":"Obesity as a chronic disease: Modern medical and lifestyle management","volume":"98","author":"Rippe","year":"1998","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.clinthera.2004.12.012_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0149-2918(03)90009-9","article-title":"Weight management and current options in pharmacotherapy: Orlistat and sibutramine","volume":"25","author":"Leung","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2004.12.012_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1467-789X.2003.00083.x","article-title":"Treatment of obesity: An update on anti-obesity medications","volume":"4","author":"Halpern","year":"2003","journal-title":"Obes Rev"},{"key":"10.1016\/j.clinthera.2004.12.012_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7258(00)00105-4","article-title":"Anti-obesity drugs: A critical review of current therapies and future opportunities","volume":"89","author":"Clapham","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2004.12.012_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2165\/00003495-199957060-00005","article-title":"Current concepts in the pharmacological management of obesity","volume":"57","author":"Carek","year":"1999","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2004.12.012_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.ijo.0800795","article-title":"Pharmacological treatment of obesity: Present status","volume":"23","author":"Scheen","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.clinthera.2004.12.012_bib12","author":"Center for Drug Evaluation and Research"},{"key":"10.1016\/j.clinthera.2004.12.012_bib13","author":"Committee on Safety in Medicines"},{"key":"10.1016\/j.clinthera.2004.12.012_bib14","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.bjp.0701311","article-title":"Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2004.12.012_bib15","first-page":"515P","article-title":"Inhibition of [3H]paroxetine binding by sibutramine, its metabolites and other antidepressants correlates with inhibition of [3H]5-hydroxytryptamine uptake","volume":"101","author":"Cheetham","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2004.12.012_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0028-3908(95)00134-4","article-title":"[3H]Nisoxetine\u2014a radioligand for noradrenaline reuptake sites: Correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments","volume":"35","author":"Cheetham","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinthera.2004.12.012_bib17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjp.0702446","article-title":"Thermogenic effects of sibutramine and its metabolites","volume":"126","author":"Connoley","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2004.12.012_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"Sibutramine. A review of its contribution to the management of obesity","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2004.12.012_bib19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/sj.bjp.0701312","article-title":"Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2004.12.012_bib20","first-page":"167P","article-title":"Effect of various monoamine receptor antagonists on the decrease in food intake induced by sibutramine in the rat","volume":"117","author":"Stricker-Krongrad","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2004.12.012_bib21","first-page":"324P","article-title":"Effect of sibutramine on tissue glucose utilisation in the rat","volume":"117","author":"Liu","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2004.12.012_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s002280050565","article-title":"Sibutramine pharmacokinetics in young and elderly healthy subjects","volume":"54","author":"Hind","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2004.12.012_bib23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0028-3908(93)90181-2","article-title":"[3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: Effect of administration of various antidepressant treatments","volume":"32","author":"Cheetham","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinthera.2004.12.012_bib24","series-title":"Sibutramine hydrochloride","first-page":"856","year":"2003"},{"key":"10.1016\/j.clinthera.2004.12.012_bib25","first-page":"322","article-title":"Changing the salt, changing the drug","volume":"266","author":"Davies","year":"2001","journal-title":"Pharm J"},{"key":"10.1016\/j.clinthera.2004.12.012_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.2600660104","article-title":"Pharmaceutical salts","volume":"66","author":"Berge","year":"1977","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2004.12.012_bib27","first-page":"114","article-title":"Phase I studies and pharmacokinetics","author":"Lloyd","year":"1994"},{"key":"10.1016\/j.clinthera.2004.12.012_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1570-0232(02)00818-8","article-title":"Determination of the active metabolite of sibutramine by liquid chromatography\u2014electrospray ionization tandem mass spectrometry","volume":"785","author":"Chen","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.clinthera.2004.12.012_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01068419","article-title":"A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability","volume":"15","author":"Schuirmann","year":"1987","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.clinthera.2004.12.012_bib30","author":"Center for Drug Evaluation and Research"},{"key":"10.1016\/j.clinthera.2004.12.012_bib31","author":"US Food and Drug Administration"},{"key":"10.1016\/j.clinthera.2004.12.012_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/phrs.1998.0405","article-title":"On the determination of bioequivalence","volume":"39","author":"Farolfi","year":"1999","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clinthera.2004.12.012_bib33","first-page":"247","article-title":"Bioavailability and bioequivalence","author":"Shargel","year":"1999"},{"key":"10.1016\/j.clinthera.2004.12.012_bib34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0149-2918(04)90071-9","article-title":"Randomized, open-label two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects","volume":"26","author":"Park","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2004.12.012_bib35","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/S0149-2918(03)80340-5","article-title":"Bioequivalence and other unresolved issues in genetic drug substitution","volume":"25","author":"Meredith","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2004.12.012_bib36","author":"Center for Drug Evaluation and Research"},{"key":"10.1016\/j.clinthera.2004.12.012_bib37","author":"Committee for Proprietary Medicinal Products"},{"key":"10.1016\/j.clinthera.2004.12.012_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003088-199325020-00003","article-title":"Clinical pharmacokinetics of drugs in obesity. An update","volume":"25","author":"Cheymol","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2004.12.012_bib39","first-page":"99","article-title":"Lean body mass in obesity","volume":"7","author":"Forbes","year":"1983","journal-title":"Int J Obes"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291804000827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291804000827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T02:22:08Z","timestamp":1548642128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291804000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0149291804000827"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2004.12.012","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}